Pacira Pharmaceuticals, Inc.(NASDAQ:PCRX) introduced a revolutionary new virtual reality simulation intended to provide clinicians with an immersive, hands-on training experience to reinforce the recommended technique for administering EXPAREL (bupivacaine liposome injectable suspension) in total knee arthroplasty (TKA) based on the infiltration protocol developed as part of the company’s ongoing Phase 4 TKA study. This cutting-edge Read more about Virtual reality and real-time haptic feedback technology to create a realistic surgical experience[…]